Reasons why clinical trial organizations use direct-to-patient distribution 2016

Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

March 2017



Survey time period

March to December 2016

Number of respondents

230 respondents

Special properties

healthcare industry professionals*

Supplementary notes

Sums may not add up to exactly 100 percent due to rounding.
* The survey was conducted among industry experts from clinical operations, clinical trial supply logistics and packaging, as well as biopharma manufacturing and supply chain organizations, representing organizations from over 20 countries and clinical supply operations worldwide.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry


About the region


Selected statistics


Other regions


Related statistics


Further related statistics

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.